Anisindione

茴茚二酮

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAnisindione
Drug Alias NameanisindionaanisindioneanisindionumMiradon
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVitamin K epOxide reductase complex subunit 1 inhibitors
TargetsVitamin K epOxide reductase complex subunit 1
Therapy Area/IndicationsThrombosis
Global Approved IndicationsThrombosis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1957/04/05
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSchering Ag
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG